Polyganics Initiates Clinical Trial For Actiseal Surgical Patch
The Dutch company received the US FDA's breakthrough device designation in 2018 for the surgical patch.
You may also be interested in...
The Netherlands-based biomaterials start-up intends to expand its platform's reach through strategic partnerships and tuck-in acquisitions.
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.